Clinical trial

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

NCT02489773

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-06-01

PhaseN/A

Study timeline

Study start (unknown)2015-06-01Date precision: month

Registry last updated2019-11-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesverified · MONDO: diabetes mellitus

Interventions

Sponsors & collaborators

Asahi Kasei Therapeutics Corporationlead sponsor

Mapped research locations

Los AngelesCalifornia, United States2 DallasTexas, United States1 AustinTexas, United States1 OmahaNebraska, United States1 New OrleansLouisiana, United States1 LexingtonKentucky, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02489773 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.